Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3692]

ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric leukaemias

ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric...

ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia

ASH 2024: Study reveals how venetoclax boosts immune response to CAR T for chronic lymphocytic leukaemia

ASH 2024 - A fibre-rich diet may help prevent complications after stem cell transplant

ASH 2024 - A fibre-rich diet may help prevent complications after stem cell transplant

ASH 2024: Ketogenic diet boosts CAR T-Cell function for better tumour control

ASH 2024: Ketogenic diet boosts CAR T-Cell function for better tumour control

Studies look at making immunotherapy both faster and stronger

Studies look at making immunotherapy both faster and stronger

B7-H4 as a therapeutic target in adenoid cystic carcinoma

B7-H4 as a therapeutic target in adenoid cystic carcinoma

Study reveals cause of common cancer immunotherapy side effect

Study reveals cause of common cancer immunotherapy side effect

New research shows how Golgi stress affects T-cells' tumour-fighting ability

New research shows how Golgi stress affects T-cells' tumour-fighting ability

Probiotic delivers anticancer drug to the gut

Probiotic delivers anticancer drug to the gut

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

More from ecancer